HHS tracking drugs made in China; global coronavirus cases increase

Feb 26, 2020 - 02:43 PM
Coronavirus Update 900x400

The Department of Health and Human Services is aware of 20 pharmaceutical products made or with a critical active ingredient solely sourced in China, but to date is not aware of any expected shortages, HHS Secretary Alex Azar told House appropriators today. He said the agency knows of two pharmaceutical makers in Hubei Province, the epicenter of the novel coronavirus (COVID-19) outbreak, but they have a large stockpile supply of advance production.

For the first time since the outbreak started, more new cases are being reported outside China than from China, the World Health Organization said today. While China continues to have the most cases overall, there are now confirmed COVID-19 cases on every continent except Antarctica, totaling more than 81,000 in 37 countries.

The Centers for Disease Control and Prevention continues to update resources, including interim guidance for businesses and employers to plan and respond to COVID-19.

For the latest information and resources, visit AHA’s coronavirus webpage.

Related News Articles

Headline
AHA blog shares ways to prevent pediatric sepsis
Pediatric sepsis is "an aggressive and unrelenting adversary that knows neither geographic nor demographic bounds," writes Chris DeRienzo, M.D., AHA’s senior…
Headline
CDC, states prepare to prevent additional cases of bird flu in humans
Centers for Disease Control and Prevention and state and territorial public health officials Friday met to discuss preparedness planning for bird flu after one…
Headline
FDA approves combo test for flu, COVID-19; alerts providers to medical device risks 
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
March United Against the Flu toolkit highlights the hopefulness of spring 
AHA is looking forward to spring and March Madness in its latest social media toolkit for hospitals’ and health systems’ use to promote vaccination against the…
Headline
FDA: Paxlovid no longer labeled for emergency use after March 8
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
CDC webinar series offers guidance to help hospitals optimize sepsis care
The Centers for Disease Control and Prevention has released a five-part webinar series on its Hospital Sepsis Program Core Elements, which offer guidance to…